Medroxyprogesterone and bone mineral density response to oestrogen.
Kanis
J A
JA
Department of Human Metabolism and Clinical Biochemistry, University of Sheffield Medical School, UK.
D000368:Aged; D015519:Bone Density / Q000187:drug effects*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007044:Hysterectomy; D008159:Lumbar Vertebrae / Q000187:drug effects / Q000502:physiology; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use*; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D013997:Time Factors
D004966:Estrogens, Conjugated (USP); D017258:Medroxyprogesterone Acetate